Baker Bros. Advisors’s BioNTech BNTX Stock Holding History

Baker Bros. Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1M	Hold	119,743	–	–	0.06%	67
2026 Q1	$10.6M	Sell	119,743 -249,180	-68%	-$25.6M	0.06%	67
2025 Q4	$35.1M	Hold	368,923	–	–	0.21%	40
2025 Q3	$36.4M	Hold	368,923	–	–	0.26%	38
2025 Q2	$39.3M	Buy	368,923 +323,892	+719%	+$32.7M	0.38%	29
2025 Q1	$4.1M	Hold	45,031	–	–	0.05%	63
2024 Q4	$5.13M	Buy	+45,031	New	+$5.14M	0.05%	67

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Baker Bros. Advisors's BNTX Position: Q2 2026 in Review

Baker Bros. Advisors held its BioNTech (BNTX) position steady in Q2 2026 at 119,743 shares worth $11.1M. The position accounts for 0.06% of the portfolio, ranked #67.

Baker Bros. Advisors first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $39.3M in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Baker Bros. Advisors held 119,743 shares of BioNTech worth $11.1M as of Q2 2026.
Baker Bros. Advisors left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.06% of Baker Bros. Advisors's portfolio in Q2 2026, its #67 holding.
Baker Bros. Advisors first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
Baker Bros. Advisors's BioNTech position peaked at $39.3M in Q2 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.